When Genome-wide HRD severity is scored, studies show these scores correlate to PARP inhibitor response. In this webinar the speakers will review their experiences using OncoScan, a whole-genome ...

Next-generation-sequencing-based homologous recombination deficiency (HRD) assay based on QIAGEN’s QIAseq xHYB technology, QIAGEN Digital Insight solutions, and Myriad’s proprietary, FDA ...

In the following interview, Ludmil B. Alexandrov, PhD, of the Moores Cancer Center, elaborates on the findings and discusses the pros and cons of using AI to predict HRD.